Literature DB >> 1538224

HTLV-I infection and neurological disease in Rio de Janeiro.

A de Q Araujo1, A Ali, A Newell, A G Dalgleish, P Rudge.   

Abstract

Fifty patients with chronic neurological diseases attending a clinic in Rio de Janeiro, Brazil, were examined for evidence of HTLV-I infection. Fifteen of 27 with progressive paraparesis of obscure origin had antibodies to HTLV-I in high titre in their serum samples, and 10 of 13 studied had antibodies in their cerebrospinal fluid. The clinical features of the antibody positive patients were similar to those of patients with HTLV-I associated myelopathy from other countries except that half of the Brazilian patients were white. Seven patients had multiple sclerosis and one of these had antibodies to HTLV-I in the serum. None of the eight patients with motor neuron disease and four with polymyositis had HTLV-I antibodies in their serum samples.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538224      PMCID: PMC488982          DOI: 10.1136/jnnp.55.2.153

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  PCR analysis of DNA from multiple sclerosis patients for the presence of HTLV-I.

Authors: 
Journal:  Science       Date:  1989-11-10       Impact factor: 47.728

2.  Tropical spastic paraparesis in Northeastern Brazil.

Authors:  C M Costa; M R Salgueiro; H Carton; O C Do Vale; A M De Arruda
Journal:  Arq Neuropsiquiatr       Date:  1989-06       Impact factor: 1.420

3.  HTLV-I associated myelopathy, a new clinical entity.

Authors:  M Osame; K Usuku; S Izumo; N Ijichi; H Amitani; A Igata; M Matsumoto; M Tara
Journal:  Lancet       Date:  1986-05-03       Impact factor: 79.321

4.  Antibodies to HTLV-I in Japanese immigrants in Brazil.

Authors:  T Kitagawa; M Fujishita; H Taguchi; I Miyoshi; H Tadokoro
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

5.  Tropical spastic paraparesis. A clinical study of 50 patients from Tumaco (Colombia) and review of the worldwide features of the syndrome.

Authors:  G C Román; L N Román
Journal:  J Neurol Sci       Date:  1988-10       Impact factor: 3.181

6.  Association of a particular amino acid sequence of the HLA-DR beta 1 chain with HTLV-I-associated myelopathy.

Authors:  K Usuku; M Nishizawa; K Matsuki; K Tokunaga; K Takahashi; N Eiraku; M Suehara; T Juji; M Osame; T Tabira
Journal:  Eur J Immunol       Date:  1990-07       Impact factor: 5.532

7.  Antibody to human T-lymphotropic virus type 1 in West-Indian-born UK residents with spastic paraparesis.

Authors:  M Newton; K Cruickshank; D Miller; A Dalgleish; P Rudge; S Clayden; I Moseley
Journal:  Lancet       Date:  1987-02-21       Impact factor: 79.321

8.  HIV-1, HIV-2, and HTLV-I infection in high-risk groups in Brazil.

Authors:  E Cortes; R Detels; D Aboulafia; X L Li; T Moudgil; M Alam; C Bonecker; A Gonzaga; L Oyafuso; M Tondo
Journal:  N Engl J Med       Date:  1989-04-13       Impact factor: 91.245

9.  Seroepidemiologic survey for antibodies to human retroviruses in human and non-human primates in Brazil.

Authors:  M J Andrada-Serpa; J Tosswill; D Schor; D Linhares; J Dobbin; M S Pereira
Journal:  Int J Cancer       Date:  1989-09-15       Impact factor: 7.396

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  1 in total

1.  Myelopathy associated with human T cell lymphotropic virus type 1 in a white European native to England.

Authors:  A Ali; P Rudge
Journal:  BMJ       Date:  1992-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.